tiprankstipranks
Fuji Pharma Co., Ltd. (JP:4554)
:4554
Japanese Market
4554
Fuji Pharma Co., Ltd.
RESEARCH TOOLSreports

Fuji Pharma Co., Ltd. (4554) Income Statement

0 Followers

Fuji Pharma Co., Ltd. Income Statement

Last quarter (Q4 2025), Fuji Pharma Co., Ltd.'s total revenue was ¥14.72B, an increase of 13.40% from the same quarter last year. In Q4, Fuji Pharma Co., Ltd.'s net income was ¥1.17B. See Fuji Pharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
¥ 51.68B¥ 46.14B¥ 40.89B¥ 35.43B¥ 33.99B
Gross Profit
¥ 19.29B¥ 16.51B¥ 15.37B¥ 13.62B¥ 14.13B
Operating Expenses
¥ 14.30B¥ 12.63B¥ 11.52B¥ 9.84B¥ 10.79B
Depreciation and Amortization
¥ 3.96B¥ 3.68B¥ 3.02B¥ 2.75B¥ 2.11B
EBITDA
¥ 8.96B¥ 7.56B¥ 6.88B¥ 6.52B¥ 5.46B
Operating Income
¥ 4.99B¥ 3.88B¥ 3.86B¥ 3.78B¥ 3.35B
Other Income/Expenses
¥ -990.00M¥ 4.39B¥ 540.00M¥ -55.00M¥ 22.00M
Pretax Income
¥ 4.00B¥ 8.28B¥ 4.40B¥ 3.72B¥ 3.37B
Net Income
¥ 3.00B¥ 6.15B¥ 3.44B¥ 2.70B¥ 2.43B
Per Share Metrics
Basic EPS
¥ 122.93¥ 252.81¥ 141.35¥ 110.98¥ 90.52
Diluted EPS
¥ 122.93¥ 252.81¥ 141.35¥ 110.98¥ 90.52
Weighted Average Shares Outstanding
 24.40M 24.31M 24.30M 24.29M 26.87M
Weighted Average Shares Outstanding (Diluted)
 24.40M 24.31M 24.30M 24.29M 26.87M
Currency in JPY

Fuji Pharma Co., Ltd. Earnings and Revenue History